3Lim KA,Kim SH,Huh J,et al.Somatostatin for postoperative chylothorax after surgery for children with congenital heart disease[J].J Korean Med Sci,2005,20(6):947-951.
4Carcoforo P,Soliani G,Maestroni U,et al.Octreotide in the treatment of lymphorrhea after axillary node dissection:a prospective randomized controlled trial[J].J Am Coll Surg,2003,196(3):365-369.
5Ulibarri JI,Sanz Y,Fuentes C,et al.Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin[J].Lancet,1990,336 (8709):258.
6Gossum V,Stefanidis C,Franquen D.Lack of effect of somatostatin and analogues in lymphorrhagia from ruptured thoracic duct[J].Lancet,1992,339(8791):491-492.
7Kelly RF,Shumway SJ.Conservative management of postoperative chylothorax using somatostatin[J].Ann Thorac Surg,2000,69(6):1944-1945.
8Gabbieri D,Bavutti L,Zaca F,et al.Conservative treatment of postoperative chylothorax with octreotide[J].Ital Heart J,2004,5(6):479-482.
3Ferrer J, Montes JF, Villarino MA, et al. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis [ J ]. Chest,2002,122 ( 3 ) : 1018 - 1027.
4Mincher L, Evans J, Jenner MW, et al. The successful treatment of chylous effusions in malignant disease with octreotide [ J ]. Clin Oncol, 2005,17(2) :118 - 121.
5Collard JM, Laterre PF, Boemer F, et al. Conservative treatment of postsurgical lymphatic leaks with somatostatin-14 [ J ]. Chest, 2000,117 (3) :902 - 905.
6Nakabayashi H, Sagara H, Usukura N, et al. Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomized dogs [J]. Diabetes, 1981,30 ( 5 ) :440 - 445.
7Markham KM, Glover JL, Welsh RJ, et al. Octreotide in the treatment of thoracic duct injuries [ J ]. Am Surg, 2000,66 ( 12 ) : 1165 - 1167.
8Buettiker V, Hug MI, Burger R,et al. Somatostatin :a new therapeutic option for the treatment of chylothorax [ J ]. Intensive Care Med, 2001, 27(6):1083-1086.
9Ulibarri JI, Sanz Y, Fuentes C, et al. Reduction of lymphorrhagia from ruptured thoracic duct bysomatostatin [ J]. Lancet, 1990, 3369(8709) :258.
10Mincher L, Evans J, Jenner MW, et al. The successful treatment of chylous effusions in malignant disease with octreotide[J]. Clin Oncol, 2005, 17(2) :118 - 121.
